Heart Transplant Market Growth Analysis Research Report segmented by Type (Ventricular Assist Devices, Total Artificial Hearts, Others) and by End User (Hospitals, Cardiac Institutes, Others), and Regional Forecast till 2030

5/5

( 21 votes )

Format :

Summary TOC Segmentation Methodology Infographics

Heart Transplant Market Snapshot

“The Heart Transplant Market to grow from USD 7566 Million in 2023 to USD 10890 Million by 2030, at a CAGR of 10.1%.”

Heart transplants are used for patients with end-stage heart failure or severe coronary artery disease who have failed other non-surgical treatments.

In 2018, the most popular surgery involved a working heart from a deceased organ donor, with the recipient's damaged heart left in situ to support the donor heart. This less common heterotopic transplant operation involved the patient's own heart being removed and replaced with the donor heart.

Over half of the 3,500 heart transplants in the US occur annually, with a typical post-operative survival time of fifteen years. Despite its life-saving nature, heart transplantation is not considered a cure for heart disease.

At the University of Maryland Medical Center, David Bennett, 57, of Maryland, became the first person to undergo a gene-edited pig heart transplant on January 7, 2022. Because of the patient's history of heart failure and irregular heartbeat, surgeons were forced to use a genetically engineered pig heart for David's transplant because he was not going to be able to obtain a human heart.

Bennett passed away on March 8, 2022, at the University of Maryland Medical Center, two months later.

Heart Transplant Market | Market Report Service

Heart transplants are performed when alternative therapies for cardiac issues fail and lead to heart failure in adults.

Cardiomyopathy is a condition characterized by the weakening of the heart muscle.
Coronary artery disease is a serious health issue characterized by the buildup of plaque in the arteries.
Heart valve disease is a serious health issue characterized by the inability to properly close the valves in the heart.
Congenital heart defect is a heart problem.
Ventricular arrhythmias are recurrent irregular cardiac rhythms that are dangerous and untreatable.
An earlier heart transplant attempt failed.

>>>Download Sample Report Now:https://marketreportservice.com/request-sample/heart-transplant-market-54709

Segment Analysis

A ventricular assist device (VAD) is a mechanical pump that aids in supporting blood flow and heart function in individuals with weak or failing hearts.

There are various types of VADs, such as:

The left ventricular assist device (LVAD) is the most popular type of VAD, aiding in the efficient pumping of oxygen-rich blood from the heart to the body.
The right ventricular assist device (RVAD) is used to pump blood with low oxygen content from the right side of the heart into the lungs.
The simultaneous use of both LVAD and RVAD is accompanied by the use of a biventricular assist device (BIVAD).
TandemHeartTM and Impella percutaneous ventricular assist devices are temporary, insertable devices without open cardiac surgery, implanted using groin-piercing catheters.

A Total artificial heart is an implanted pump that replaces damaged heart valves and ventricles. The ventricles pump blood to the lungs and other organs. Polyurethane is used for the ventricles, and a driver operates the pump from outside the body. The pump and driver replace the function of a healthy heart, facilitating blood flow to and from the heart.

Growth Drivers

The heart transplant market is driven by the increasing incidence of heart failure and coronary artery disease, with approximately 26 million people experiencing heart failure worldwide. The market also grows due to the increasing number of elderly individuals and those with high blood cholesterol.

Over 1.5 billion people over 50, comprising 22% of the global population, are experiencing an expanding heart transplant market due to improved allocation policies, donor processes, and technology. However, the main obstacle is the shortage of qualified surgeons and donors, which is a significant hurdle in this market.

The global increase in cardiovascular disease cases and the rise in high blood cholesterol among the aging population and high blood pressure individuals are driving the demand for heart surgery and therapies, as well as the rising number of heart failure patients, thereby increasing the cost of heart transplants worldwide.

Competitive Landscape of the Heart Transplant Market Analysis

Apaxis Medical, Inc.
CardiacAssist Inc.
SynCardia Systems, LLC
Optum Inc.
CARMAT
HeartWare International Inc.
Thoratec Corporation
Calon Cardio

New Developments in Heart Transplant Market

July 11, 2023- SynCardia Updates Total Artificial Heart Labeling with Real World Data

SynCardia Systems, LLC., a Picard Medical Company, announced that the U.S. Food and Drug Administration (FDA) has approved an update of the SynCardia TAH-t label with real world data further confirming the safety and performance of the Companion 2 Driver.

Tucson, AZ. SynCardia Systems, LLC., a Picard Medical Company, today announced that the U.S. Food and Drug Administration (FDA) has approved an update of the SynCardia TAH-t label with real world data further confirming the safety and performance of the Companion 2 Driver.

October 2, 2023- Artificial heart maker Carmat's future seen in hands of core backers.

The HeartMate 3 Heart Pump's modified labelling for use in paediatric patients with advanced, refractory left ventricular heart failure has been approved by the FDA.

Regional Analysis of Global Heart Transplant Industry

North America holds the largest market share for heart transplants due to high healthcare costs and an increase in patients with cardiomyopathy, heart valve disease, and coronary artery disease. The United States has the most market share, while Canada has the highest rate of growth.

In 2022, Europe's heart transplant market grew significantly due to increased government funding for R&D projects, with the UK being the fastest-growing market and Germany holding the largest market share, primarily due to the development of practical cardiac transplant devices.

The Asia Pacific region has experienced rapid growth in the heart transplant industry due to its lower cost in developing countries like China and India. This has attracted a large number of patients worldwide. The demand for superior heart transplant devices is expected to drive the application of advanced technology.

Segments Covered in the Heart Transplant Market Report

Heart Transplant Market Segment by Types

Ventricular Assist Devices
Total Artificial Hearts
Others

Heart Transplant Market Segment by End-Users

Hospitals
Cardiac Institutes
Others

Heart Transplant Market by Region

North America
- US
- Canada
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
Rest of the World
Middle East
Africa
Latin America

Frequently Asked Questions

What are some applications of Heart Transplant?

Heart transplantation is a last resort operation where a failing heart is replaced with a healthy donor heart, typically reserved for those whose condition has not improved adequately with medication or treatments.

What is the expected growth rate of the Heart Transplant market over the next 7 years?

The Heart Transplant Market to grow from USD 11.34 Billion in 2023 to USD 22.56 Billion by 2030, at a CAGR of 10.1%.

Who are the major players in the Heart Transplant market and what is their market share?

Apaxis Medical, Inc., CardiacAssist Inc., SynCardia Systems, LLC, Optum Inc., CARMAT, HeartWare International Inc., Thoratec Corporation, Calon Cardio, are prominent players operating and dominating in the market.

Who are the top 3 Heart Transplant Market Key Vendors?

Apaxis Medical, Inc., CardiacAssist Inc., SynCardia Systems, are key players in the Heart Transplant market.

Which geographical areas dominate the worldwide market for Heart Transplant?

North America region are emerging as the top regional markets for Heart Transplant solutions.

Base Year:2022

Historical Data:2018-2022

No of Pages:122

Select Licence Type

Single User

US$ 2499

Multi User

US$ 3499

Corporate User

US$ 4499

Only one user can access the report. It cannot be printed or shared. Delivery in online PDF.

US $ 2499

Multiple users can access the report. It cannot be printed or shared. Delivery in online PDF.

US $ 3499

The entire organization can use the report. It can be printed and shared. Delivery in PDF and Excel. Free update of the report after 1 year.

US $ 4499

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Phone:

Toll Free:

Email: sales@marketreportservice.com

Heart Transplant Market Growth Analysis Research Report segmented by Type (Ventricular Assist Devices, Total Artificial Hearts, Others) and by End User (Hospitals, Cardiac Institutes, Others), and Regional Forecast till 2030

1. Introduction

2. Executive Summary

3. Research Methodology

4. Heart Transplant Market Landscape

5. Heart Transplant Market - Key Industry Dynamics

6. Heart Transplant Market - Global Market Analysis

7. Heart Transplant Market Analysis - Surgery Type

8. Heart Transplant Market Analysis - Type

9. Heart Transplant Market Analysis - End User

10. Heart Transplant Market - Geographical Analysis

11. Industry Landscape

12. COMPANY PROFILES

13. Appendix

List of Tables

List of Figures

Select Licence Type

Need a Discount? Get in touch with us for special pricing

Connect with our sales team

Industry Verticals

Quick Links

Legal

Subscribe Us

Office Addresses